About Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
Clinical Trials at Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
During the past decade, Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
According to Clinical.Site data, the most researched conditions in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center" are
"HER2-Positive Primary Breast Cancer" (1 trials), "Non Small Cell Lung Cancer ALK Positive or ROS1 Positive" (1 trials), "Pancreatic Cancer Non-resectable" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
Most popular intervention types in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "DS-8201a" (1 trials), "Lorlatinib" (1 trials), "Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX" (1 trials), "Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX" (1 trials) and "T-DM1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
The vast majority of trials in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center" are
3 trials for "All" genders.
Clinical Trials Status at Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center
Currently, there are NaN active trials in "Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Elmhurst Memorial Hospital - Nancy W. Knowles Cancer Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".